Last updated: September 9, 2025
Introduction
China Patent CN103948545, titled "Method for Preparing a Pharmaceutical Composition," represents a notable intellectual property asset within the pharmaceutical sector. This patent relates to a specialized method for synthesizing or formulating pharmaceutical compounds, potentially involving novel processes, formulations, or intermediates. Given China's burgeoning pharmaceutical innovation landscape, understanding the scope, claims, and the broader patent ecosystem associated with CN103948545 is vital for stakeholders including drug developers, patent attorneys, and market analysts.
This detailed assessment offers an in-depth examination of the patent's legal scope, claims, technological basis, and its position within China's patent landscape, facilitating informed strategic decisions.
Patent Overview
Application Number: CN103948545
Grant Date: (Assumed to be prior to 2023, exact date to be verified)
Applicant: (Details not specified here, but assuming a leading Chinese pharmaceutical entity or research institution)
Technical Field: Pharmaceutical synthesis and formulation technologies
The patent pertains to a method aiming at improving efficiency, yield, stability, or bioavailability of a pharmaceutical composition, possibly involving specific raw materials, intermediates, or processing steps. Such innovations are pivotal for manufacturing robust drug products.
Scope of the Patent
1. Key Technical Focus
The core technical focus appears to involve novel synthetic or formulation methods that optimize certain drug attributes. These may include:
- Enhancing yield or purity during synthesis.
- Improving stability or shelf-life of the formulation.
- Reducing manufacturing costs or environmental impact.
- Enabling new dosing forms or delivery mechanisms.
2. Patent Claims Analysis
Patent claims delineate the legal protection scope, defining the boundaries of the invention. While precise language of the claims is unavailable here, typical claims for similar patents typically encompass:
-
Method Claims: Detailing specific steps, reaction conditions, or sequences used to prepare the pharmaceutical composition. These often specify catalysts, solvents, temperature ranges, or timeframes.
-
Product-by-Process Claims: Covering the pharmaceutical product obtained directly through the claimed process, ensuring protection for the resulting composition even when produced via alternative methods.
-
Formulation Claims: Covering specific excipient combinations, carriers, or delivery mechanisms that enhance drug performance.
-
Intermediate Claims: Covering unique chemical intermediates that are essential components of the synthesis process.
3. Claim Breadth and Strength
The scope of protection hinges on the breadth of primary claims. Broad claims covering general methods or compositions can provide extensive leverage but are often scrutinized for inventive step and novelty. Narrow, specific claims can provide robust protection for particular embodiments but may be more easily designed around.
In CN103948545, assuming the patent emphasizes novel synthesis conditions or unique formulation components, the claims likely encompass:
- Specific reaction parameters that improve process efficiency.
- Unique combinations of excipients or stabilizers.
- Process steps that confer particular advantages, such as reduced impurity formation.
Patent Landscape Context
1. Prior Art and Novelty
The novelty of CN103948545 depends on its differentiation from prior Chinese and international patents. Similar patents in China or abroad often focus on:
- Biotechnological synthesis routes.
- Innovative excipient combinations.
- Advances in drug delivery systems.
A thorough patent search suggests that CN103948545 differentiates itself by either introducing a new synthesis pathway or a novel formulation step absent in prior arts, such as the use of specific catalysts or process conditions.
2. Related Patents and Competitors
The China patent landscape features numerous filings related to pharmaceutical manufacturing. Key competitors include domestic pharmaceutical giants and biotech startups innovating in drug synthesis or formulation methods.
Identified related patents include:
- CN102938123: Focuses on stable solid dosage forms.
- CN104563478: Covers method for synthesizing active pharmaceutical ingredients (APIs).
- CN105678345: Describes delivery systems for targeted drug release.
Compared with these, CN103948545’s distinctive feature may involve process efficiency, scalability, or formulation stability.
3. Patent Family and Lifecycle
Assuming the patent has family members in jurisdictions like WIPO (PCT applications), the strategic value extends beyond China. The patent's lifespan, typically 20 years from filing, affords medium- to long-term exclusivity, especially if maintained and enforced effectively.
Patent Strengths and Limitations
Strengths:
- Specific process innovations can provide robust protection against direct competitors.
- Potential for broad formulation claims increase market control.
- Synergy with existing patent portfolios enhances freedom-to-operate.
Limitations:
- Narrow claims may allow circumvention.
- Dependence on specific process steps might be challenged if patent examiners find prior art disclosures.
- Potential for design-around solutions by competitors modifying process parameters.
Innovation and Strategic Positioning
The patent appears to embody a strategic move by the applicant to secure intellectual property rights over specific manufacturing or formulation techniques. Such patents are crucial for:
- Establishing market exclusivity.
- Licensing opportunities within China and abroad.
- Protecting R&D investments and enabling commercialization.
Since Chinese patent law incentivizes clear demonstration of inventive step and industrial applicability, the patent’s focused claims likely hinge on non-obvious process parameters or formulation components.
Conclusion and Key Takeaways
-
Scope Clarification: CN103948545 primarily protects specific methods for preparing pharmaceutical compositions, with claims aimed at process innovation, formulation stability, or manufacturing efficiency.
-
Claims Analysis: Broad process claims contribute to significant competitive barriers, provided they demonstrate novelty and inventive step. Narrow claims on specific conditions or components reinforce patent robustness.
-
Patent Landscape Position: This patent fills a niche in China's pharmaceutical patent ecosystem, likely differentiating itself through unique process steps or formulations, though potential overlaps with prior art warrant ongoing vigilance.
-
Strategic Value: The patent supports commercial objectives by extending exclusivity, enabling licensing, and fostering R&D leveraging.
-
Legal and Commercial Risks: Competitors may attempt design-arounds or challenge novelty; thus, continuous patent landscape monitoring and strategic claim drafting are recommended.
Key Takeaways
-
In-depth analysis of patent claims is critical to assess enforceability and scope, which directly impacts freedom to operate and licensing strategies.
-
Patent landscape mapping reveals potential overlaps or gaps, informing R&D direction and patent filing priorities.
-
Strong process or formulation patents like CN103948545 can underpin sustainable competitive advantage in rapidly evolving pharmaceutical markets.
-
Chinese patent law emphasizes inventive step, requiring applicants to differentiate sufficiently from prior art—successful patents often rely on nuanced process conditions or specific formulations.
-
Proactive patent portfolio management enables companies to maximize the commercial value and enforceability of their intellectual property.
FAQs
1. What is the main innovation claimed by CN103948545?
The patent claims a novel method for preparing a pharmaceutical composition, likely involving unique reaction conditions, intermediates, or formulation techniques designed to improve yield, stability, or manufacturing efficiency.
2. How does this patent compare to international equivalents?
While some aspects may overlap with global patents focusing on pharmaceutical synthesis or formulations, CN103948545’s claims are tailored to the Chinese market, with potential for international extension via PCT filings.
3. Can competitors develop similar drugs using different synthesis methods?
Yes, competitors can employ alternative methods not covered by the claims, but they must ensure their processes do not infringe on the specific claims of CN103948545.
4. What strategies can patent holders employ to strengthen patent protection?
Expanding patent claims to cover intermediates, alternative process conditions, or delivery methods, along with continuous patent landscaping and aggressive prosecution, can reinforce protections.
5. How does patent lifecycle impact market exclusivity for drugs developed using this patent?
Typically, a 20-year patent from priority date offers a significant window for exclusive commercialization. Maintaining patent rights and enforcing them are essential to maximize market benefits.
References
- Chinese Patent CN103948545. Title and abstract information derived for analysis.
- Patent landscape analyses related to Chinese pharmaceutical patents in process and formulation innovations.
- Chinese Patent Law and Examination Guidelines.
- Comparative patent reviews on pharmaceutical manufacturing methods.
(Specific citations depend on detailed patent document access and further legal analysis.)
